Greta Mulders: Nursing Leadership in Haemophilia Gene Therapy
Greta Mulders, Nurse practitioner at Erasmus MC, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Haemophilia, adding:
”Proud to share our publication: ‘Defining the Role of Nurses in Gene Therapy for Haemophilia.’
As healthcare evolves, so does the role of nursing; becoming ever more central in guiding patients through innovative treatments such as gene therapy.
This paper highlights how essential that role remains, especially in emerging therapies where patient education, support, and long-term follow-up are crucial.
Thank you to Simon Flechter, Aysen Tasgin, Marlene Beijlevelt, Marica Moro for working on this project together!
Special thanks to Prof Kate Khair for the inspiration and encouragement to think critically and aim higher.
On to new questions and future research!”
Title: Defining the Role of Nurses in Gene Therapy for Haemophilia
Authors: Greta Mulders, Simon Fletcher, Aysen Tasgin, Marica Moro, Marléne Beijlevelt, Kate Khair
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’